Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development
Michael V. Holmes, Tom G. Richardson, Brian A. Ference, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 435-453
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Mendelian randomization
Eleanor Sanderson, M. Maria Glymour, Michael V. Holmes, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 1201
Mendelian Randomization: Concepts and Scope
Rebecca C. Richmond, George Davey Smith
Cold Spring Harbor Perspectives in Medicine (2021) Vol. 12, Iss. 1, pp. a040501-a040501
Open Access | Times Cited: 510
Guidelines for performing Mendelian randomization investigations: update for summer 2023
Stephen Burgess, George Davey Smith, Neil M Davies, et al.
Wellcome Open Research (2023) Vol. 4, pp. 186-186
Open Access | Times Cited: 343
Artificial intelligence in cancer target identification and drug discovery
Yujie You, Xin Lai, Yi Pan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 219
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Tom G. Richardson, Genevieve M Leyden, Qin Wang, et al.
PLoS Biology (2022) Vol. 20, Iss. 2, pp. e3001547-e3001547
Open Access | Times Cited: 184
Using Mendelian Randomization to Improve the Design of Randomized Trials
Brian A. Ference, Michael V. Holmes, George Davey Smith
Cold Spring Harbor Perspectives in Medicine (2021), pp. a040980-a040980
Open Access | Times Cited: 178
Pathogenesis and management of abdominal aortic aneurysm
Jonathan Golledge, Shivshankar Thanigaimani, Janet T. Powell, et al.
European Heart Journal (2023) Vol. 44, Iss. 29, pp. 2682-2697
Open Access | Times Cited: 104
Using genetic association data to guide drug discovery and development: Review of methods and applications
Stephen Burgess, Amy M. Mason, Andrew J. Grant, et al.
The American Journal of Human Genetics (2023) Vol. 110, Iss. 2, pp. 195-214
Open Access | Times Cited: 101
Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease
Ziang Li, Bin Zhang, Qing‐Rong Liu, et al.
EBioMedicine (2023) Vol. 90, pp. 104543-104543
Open Access | Times Cited: 83
Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function
Daniel B. Rosoff, Andrew S. Bell, Jeesun Jung, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 7, pp. 653-662
Open Access | Times Cited: 82
Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity
Satoshi Yoshiji, Guillaume Butler‐Laporte, Tianyuan Lu, et al.
Nature Metabolism (2023) Vol. 5, Iss. 2, pp. 248-264
Open Access | Times Cited: 58
Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
Liwan Fu, Qin Liu, Hong Cheng, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 2
(Apo)Lipoprotein Profiling with Multi‐Omics Analysis Identified Medium‐HDL‐Targeting PSRC1 with Therapeutic Potential for Coronary Artery Disease
Yingmei Li, Sihan Wang, Ling Liu, et al.
Advanced Science (2025)
Open Access | Times Cited: 2
Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases
Huiling Zhao, Humaria Rasheed, Therese Haugdahl Nøst, et al.
Cell Genomics (2022) Vol. 2, Iss. 11, pp. 100195-100195
Open Access | Times Cited: 52
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
Eleanor L. Watts, Aurora Perez‐Cornago, Georgina K. Fensom, et al.
International Journal of Epidemiology (2022) Vol. 52, Iss. 1, pp. 71-86
Open Access | Times Cited: 39
From the garden to the clinic: how Mendelian randomization is shaping up atherosclerotic cardiovascular disease prevention strategies
Benoît J. Arsenault
European Heart Journal (2022) Vol. 43, Iss. 42, pp. 4447-4449
Open Access | Times Cited: 39
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
Si Fang, James Yarmolinsky, Dipender Gill, et al.
PLoS Medicine (2023) Vol. 20, Iss. 1, pp. e1003988-e1003988
Open Access | Times Cited: 33
The association between genetically elevated polyunsaturated fatty acids and risk of cancer
Philip Haycock, Maria Carolina Borges, Kimberley Burrows, et al.
EBioMedicine (2023) Vol. 91, pp. 104510-104510
Open Access | Times Cited: 28
SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
Jiang Li, Yuefeng Yu, Ying Sun, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 28
From genetic associations to genes: methods, applications, and challenges
Ting Qi, Liyang Song, Yazhou Guo, et al.
Trends in Genetics (2024) Vol. 40, Iss. 8, pp. 642-667
Open Access | Times Cited: 15
A review of recent advances in drug loading, mathematical modeling and applications of hydrogel drug delivery systems
Xiaohan Hu, Chenyun Zhang, Yingshuo Xiong, et al.
Journal of Materials Science (2024) Vol. 59, Iss. 32, pp. 15077-15116
Closed Access | Times Cited: 9
Body Fat Distribution and Ectopic Fat Accumulation as Mediator of Diabetogenic Action of Lipid-Modifying Drugs
Yuanlong Hu, Xinhai Cui, Mengkai Lu, et al.
Mayo Clinic Proceedings (2025)
Closed Access | Times Cited: 1
HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease – Insights from randomized clinical trials and human genetics
Emilie Westerlin Kjeldsen, Jesper Qvist Thomassen, Ruth Frikke‐Schmidt
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159063-159063
Open Access | Times Cited: 44
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
Eleanor L. Watts, Aurora Perez‐Cornago, Georgina K. Fensom, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 7, pp. 1033-1046
Open Access | Times Cited: 38
Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: A multivariable Mendelian randomization study
Joshua A. Bell, Tom G. Richardson, Qin Wang, et al.
The Lancet Regional Health - Europe (2022) Vol. 21, pp. 100457-100457
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top